APYX Apyx Medical Corporation
$2.50▲ +1.63%
Healthcare
Other
Volume 46.2K
Avg Volume (10D) 151.6K
Key Metrics & Fundamentals
Market Cap
$105.31M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.25 - 5.08
% vs 50 MA
-10.63%
% vs 200 MA
-30.94%
RSI-14
44.2
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.42
Free Cash Flow
-$3.56M
Gross Rev
$13.88M
Gross Profit
$8.87M
EBITDA
-$1.36M
COGS
$5.01M
Operating Exp
$10.68M
Operating Income
-$1.81M
EBIT
-$1.81M
Pretax Income
-$2.95M
Net Income
-$3.24M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
GlobeNewswire · Oct 22, 2026 8:00 AM ET
Apyx Medical Corporation to Participate in Upcoming Investor Conferences
GlobeNewswire · Oct 21, 2026 8:00 AM ET
Maxim Initiates Apyx Medical at Buy With $6 Price Target
MT Newswires · Sep 29, 2026 8:10 AM ET
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
GlobeNewswire · Sep 29, 2026 8:00 AM ET
Cold Plasma Market Forecasts Growth from $3.32B (2025) to $8.45B by 2032, Profiling Nordson Corporation, Apyx Medical, Plasmatreat & Enercon Industries
GlobeNewswire · Sep 24, 2026 9:08 AM ET
Cold Plasma Market Forecasts Growth from $167.8M (2025) to $495.9M by 2033, Profiling Apyx Medical, Neoplas Med, Adtec Healthcare & 5 Other Key Players
GlobeNewswire · Sep 15, 2026 4:35 AM ET
Apyx Medical (APYX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 8:13 PM ET
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring
MarketBeat · Aug 11, 2026 8:04 PM ET
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ...
GuruFocus.com · Aug 7, 2026 1:11 AM ET
Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 6, 2026 7:10 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See APYX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.